Clinical Trials Browser

Phase 3 × NIH × Prostatic Neoplasms × Clear all

NCT00942331 2023-10-16

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Phase 3 Completed

506 enrolled 13 charts

Carcinoma, Transitional Cell, Prostatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00004635 2018-05-22

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

Phase 3 Completed

159 enrolled 9 charts

Neoplasms, Prostatic Neoplasms

NCT00003734 2016-07-21

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3 Unknown

Prostatic Neoplasms

NCT00110214 2014-05-09

Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 3 Completed

1,050 enrolled 13 charts

Prostatic Neoplasms

NCT00767286 2014-01-28

Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00398281 2014-01-10

Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00003290 2013-12-04

Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00002703 2013-11-06

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00005075 2013-11-06

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms

NCT00363285 2013-08-26

Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

Phase 3 Unknown

Prostatic Neoplasms

NCT00376792 2013-08-26

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Phase 3 Unknown

Prostatic Neoplasms

NCT00796458 2013-08-12

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

Phase 3 Unknown

Pain, Prostatic Neoplasms

NCT00110162 2013-08-07

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

Phase 3 Unknown

Prostatic Neoplasms

NCT00632138 2013-08-07

Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate

Phase 3 Completed

GenitourinaryOther

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

NCT00082927 2013-06-26

Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain

Phase 3 Completed

Neoplasm Metastasis, Pain, Prostatic Neoplasms

NCT00255606 2013-06-26

Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00316927 2013-06-26

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00005623 2013-03-26

Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms, Hot Flashes

NCT00002723 2013-02-28

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00394511 2013-02-11

Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT01087268 2011-07-15

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Phase 3 Unknown

GastrointestinalGenitourinaryGynecologicSarcoma

Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Radiation Injuries, Rectal Neoplasms, Sarcoma, Testicular Neoplasms, Vaginal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT00046943 2011-02-21

Atrasentan in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00002881 2010-11-09

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00048841 2010-03-02

Prevention of Osteoporosis in Men With Prostate Cancer

Phase 3 Completed

Hypogonadism, Osteoporosis, Prostatic Neoplasms